Cost-Cutting Generics And Biosimilars Stuck In Legal Limbo

Many believe that the biosimilar industry can address the issue of spiraling drug costs, but first it has to make it through a thicket of challenges.

Leave a Reply

Your email address will not be published. Required fields are marked *